Sex pay ban paper earns a retraction after a long and winding road for an unhappy author

In March 2024, Riccardo Ciacci, an economist at the Universidad Pontificia Comillas in Spain, published a paper claiming Sweden’s ban on buying sex had increased reported rapes by as much as 62%. The finding gained attention on social media, and quickly drew criticism from others in the field. 

In particular, a group of three economists took their concerns to social media and to the journal editors, and eventually published a critique of Ciacci’s work. They claimed his analysis reports a statistical relationship not relevant to the finding described in the paper. They concluded there was no large or statistically significant finding. 

What followed was a year-long effort to fix the paper, and then ultimately, a decision to retract it. Ciacci, who was not accused of misconduct, said the retraction, which he disagrees with, has cost him a promotion and funding for future research. He also alleges he experienced an onslaught of harassment on social media. In the end, Ciacci maintains the retraction was unjustified, and critics say it came far too late. 

Continue reading Sex pay ban paper earns a retraction after a long and winding road for an unhappy author

Swedish regulators drop investigations into Chalmers’ prosthetics lab

Two Swedish agencies have closed their investigations into a high-profile research center at Chalmers University of Technology that was suspended last year for “shortcomings in the operations.” 

The Center for Bionics and Pain Research (CBPR), known for its work on restoring limb function, was scrutinized and ultimately shut down after a university investigation last April found scientists at the center conducted research without sufficient permits, had inadequate quality assurance processes and handled sensitive personal data poorly, and found “shortcomings” in legal agreements for the center’s operations. 

Now, subsequent investigations by the country’s Medical Products Agency, which regulates medical devices and clinical trials, and the Ethics Review Appeal Board have ended, with both agencies declining to pursue further action. 

Continue reading Swedish regulators drop investigations into Chalmers’ prosthetics lab